| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acarbose for the treatment of Type II diabetes: the results of a Canadian multi-centre trial
|
Josse, Robert G.
|
|
1995
|
28 |
S |
p. S167-S172
6 p.
|
article
|
| 2 |
Alternative therapeutic principles in the prevention of microvascular and neuropathic complications
|
Gries, F. Arnold
|
|
1995
|
28 |
S |
p. S201-S207
7 p.
|
article
|
| 3 |
CACN4, the major α1 subunit isoform of voltage-dependent calcium channels in pancreatic β-cells: a minireview of current progress
|
Seino, Susumu
|
|
1995
|
28 |
S |
p. S99-S103
5 p.
|
article
|
| 4 |
Clinical evaluation of glimepiride (HOE490) in NIDDM, including a double blind comparative study versus gliclazide
|
Tsumura, Ken-ichiro
|
|
1995
|
28 |
S |
p. S147-S149
3 p.
|
article
|
| 5 |
Clinical profile of glimepiride
|
Draeger, Eberhard
|
|
1995
|
28 |
S |
p. S139-S146
8 p.
|
article
|
| 6 |
Extrapancreatic effects of sulfonylurea drugs
|
Kaku, Kohei
|
|
1995
|
28 |
S |
p. S105-S108
4 p.
|
article
|
| 7 |
Extrapancreatic effects of sulfonylureas — a comparison between glimepiride and conventional sulfonylureas
|
Müller, Günter
|
|
1995
|
28 |
S |
p. S115-S137
23 p.
|
article
|
| 8 |
Influence of oral sulfonylurea agents on hepatic glucose uptake
|
Kawamori, Ryuzo
|
|
1995
|
28 |
S |
p. S109-S113
5 p.
|
article
|
| 9 |
Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitus
|
Moses, Alan C.
|
|
1995
|
28 |
S |
p. S185-S194
10 p.
|
article
|
| 10 |
Insulin secretion in obese and non-obese NIDDM
|
Cerasi, Erol
|
|
1995
|
28 |
S |
p. S27-S37
11 p.
|
article
|
| 11 |
Insulin therapy in Type II diabetes
|
Holman, R.R.
|
|
1995
|
28 |
S |
p. S179-S184
6 p.
|
article
|
| 12 |
Lessons from UK prospective diabetes study
|
Turner, R.C.
|
|
1995
|
28 |
S |
p. S151-S157
7 p.
|
article
|
| 13 |
NIDDM — the devastating disease
|
Horton, Edward S
|
|
1995
|
28 |
S |
p. S3-S11
9 p.
|
article
|
| 14 |
Pancreatic pathology in non-insulin dependent diabetes (NIDDM)
|
Clark, A.
|
|
1995
|
28 |
S |
p. S39-S47
9 p.
|
article
|
| 15 |
Pathogenesis of insulin resistance: Modulation of the insulin signal at receptor level
|
Kellerer, Monika
|
|
1995
|
28 |
S |
p. S173-S177
5 p.
|
article
|
| 16 |
Pathophysiology of non-insulin-dependent diabetes mellitus (NIDDM)
|
Beck-Nielsen, Henning
|
|
1995
|
28 |
S |
p. S13-S25
13 p.
|
article
|
| 17 |
Potassium channels in the cardiovascular system
|
Pogátsa, Gábor
|
|
1995
|
28 |
S |
p. S91-S98
8 p.
|
article
|
| 18 |
Rationale and hurdles of inhibitors of hepatic gluconeogenesis in treatment of diabetes mellitus
|
Kashiwagi, Atsunori
|
|
1995
|
28 |
S |
p. S195-S200
6 p.
|
article
|
| 19 |
Targets of therapy for NIDDM
|
Tattersall, Robert
|
|
1995
|
28 |
S |
p. S49-S55
7 p.
|
article
|
| 20 |
The β-cell response to oral hypoglycemic agents
|
Cook, Daniel L.
|
|
1995
|
28 |
S |
p. S81-S89
9 p.
|
article
|
| 21 |
The molecular interaction of sulfonylureas with β-cell ATP-sensitive K+-channels
|
Kramer, Werner
|
|
1995
|
28 |
S |
p. S67-S80
14 p.
|
article
|
| 22 |
The role of potassium channels in excitable cells
|
Edwards, Gillian
|
|
1995
|
28 |
S |
p. S57-S66
10 p.
|
article
|
| 23 |
What therapy do our NIDDM patients need? Insulin releasers
|
Crepaldi, Gaetano
|
|
1995
|
28 |
S |
p. S159-S165
7 p.
|
article
|
Journal description